Trial
NCT01865175
A Pilot Study Comparing Tolerance of Oral Heme Iron Polypeptide With Oral Ionic Iron
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Milton S. Hershey Medical Center
Collaborators
—
Condition
Iron Deficiency
Intervention
ionic iron
Why stopped
Institution required IND, although FDA did not, so institution did not allow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-09-14